#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Hrodek O. Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL–positive acute lymphoblastic leukemia

Czech version

Published in: Transfuze Hematol. dnes,20, 2014, No. 2, p. 85.
Category: Selection of press reports and books

Labels

Haematology Internal medicine Clinical oncology

Evaluation of CD45 antigen expression in patients with multiple myeloma and its effect on time to progression or relapse

Chronic myelomonocytic leukemia – a review of present diagnostic and treatment options

Elimination the risk of hepatitis B virus transfusion-transmitted infection in the phase of possible occult HBV infection

Mechanisms of immune tolerance induction of tumour cells in chronic lymphocytic leukaemia and possibilityof their detection using flow cytometry

Hrodek O. Early molecular response predicts outcomes in patients with chronic myeloid leukemia in chronic phase treated with frontline nilotinib or imatinib

Hrodek O. Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group

Hrodek O. Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism

Hrodek O. Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood

Hrodek O. Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study

Hrodek O. Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up

Hrodek O. How I treat leukemia during pregnancy

Hrodek O. What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia?

Article was published in

Transfusion and Haematology Today

Issue 2

2014 Issue 2

Most read in this issue

#ADS_BOTTOM_SCRIPTS#